Thomas Jefferson University

Medical research

Blocking crucial molecule could help treat multiple sclerosis

Reporting in Nature Immunology, Jefferson neuroscientists have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step ...

Medications

Allergy to Plavix can be overcome: study

Allergies to Plavix, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary ...

Parkinson's & Movement disorders

Parkinson's gene initiates disease outside of the brain

Until very recently, Parkinson's had been thought a disease that starts in the brain, destroying motion centers and resulting in the tremors and loss of movement. New research published this week in the journal Brain, shows ...

Medical research

Single vaccines to protect against both rabies and Ebola

Researchers from Thomas Jefferson University, among other institutions, including the National Institute of Allergy and Infectious Diseases, have developed single vaccines to protest against both rabies and the Ebola virus.

Neuroscience

Seizures begin with a muffle

Some patients describe epileptic seizures like an earthquake from within, starting slow and growing without their control. To a brain researcher, seizures are an electrical firestorm of neuronal activation in the brain. Now, ...

Oncology & Cancer

HIV drug blocks bone metastases in prostate cancer

Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. In a study published online December 1st in the journal Cancer Research, researchers show ...

page 3 from 40